A Phase I Study of Pyrimethamine in Patients With GM-2 Gangliosidosis

This study has been suspended.

( Lack of sufficient funds )

Study NCT00679744 Information provided by FDA Office of Orphan Products Development

First Received: May 15, 2008 Last Updated: October 1, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	March 2010
Estimated Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)